Bridgebio Pharma, Inc. · NASDAQ:BBIO

Apuli Maricel sold 2,000 Bridgebio Pharma, Inc. shares (Form 4)

Traded Apr 30, 2026 · Filed May 4, 2026

On Apr 30, 2026, Apuli Maricel (Chief Accounting Officer) sold 2,000 Bridgebio Pharma, Inc. shares at US$71.58 for US$143K under a trading plan, leaving 134,115 shares. Filed May 4, 2026 (Form 4).

Sold
2,000 shares
Price
US$71.58
Value
US$143K
Holding after
134,115 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Accounting Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 30, 2026Common StockSale2,000US$71.58134,115Direct

Source

View original at SEC

Related